Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids
- PMID: 35322595
- PMCID: PMC9130892
- DOI: 10.1002/advs.202103526
Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids
Abstract
Kidney organoids derived from human pluripotent stem cells (hPSCs) have extensive potential for disease modelling and regenerative medicine. However, the limited vascularization and immaturity of kidney organoids have been still remained to overcome. Extracellular matrix (ECM) can provide mechanical support and a biochemical microenvironment for cell growth and differentiation. Here in vitro methods using a kidney decellularized extracellular matrix (dECM) hydrogel to culture hPSC-derived kidney organoids, which have extensive vascular network and their own endothelial cells, are reported. Single-cell transcriptomics reveal that the vascularized kidney organoids cultured using the kidney dECM have more mature patterns of glomerular development and higher similarity to human kidney than those cultured without the kidney dECM. Differentiation of α-galactosidase A (GLA)-knock-out hPSCs generated using CRISPR/Cas9 into kidney organoids by the culture method using kidney dECM efficiently recapitulate Fabry nephropathy with vasculopathy. Transplantation of kidney organoids with kidney dECM into kidney of mouse accelerates the recruitment of endothelial cells from the host mouse kidney and maintains vascular integrity with the more organized slit diaphragm-like structures than those without kidney dECM. The kidney dECM methodology for inducing extensive vascularization and maturation of kidney organoids can be applied to studies for kidney development, disease modeling, and regenerative medicine.
Keywords: extracellular matrix; kidney; organoid; vascularization.
© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis.Adv Mater. 2024 Aug;36(34):e2400306. doi: 10.1002/adma.202400306. Epub 2024 Jun 12. Adv Mater. 2024. PMID: 38762768
-
Decellularized Extracellular Matrix for Remodeling Bioengineering Organoid's Microenvironment.Small. 2023 Jun;19(25):e2207752. doi: 10.1002/smll.202207752. Epub 2023 Mar 16. Small. 2023. PMID: 36929582 Review.
-
Human Placenta Decellularized Extracellular Matrix Hydrogel Promotes the Generation of Human Spinal Cord Organoids with Dorsoventral Organization from Human Induced Pluripotent Stem Cells.ACS Biomater Sci Eng. 2024 May 13;10(5):3218-3231. doi: 10.1021/acsbiomaterials.4c00067. Epub 2024 Apr 9. ACS Biomater Sci Eng. 2024. PMID: 38593429
-
Maturation of Nephrons by Implanting hPSC-derived Kidney Progenitors Under Kidney Capsules of Unilaterally Nephrectomized Mice.Curr Stem Cell Res Ther. 2023;18(4):551-559. doi: 10.2174/1574888X17666220818101503. Curr Stem Cell Res Ther. 2023. PMID: 35984016
-
The endothelium, a key actor in organ development and hPSC-derived organoid vascularization.J Biomed Sci. 2020 May 22;27(1):67. doi: 10.1186/s12929-020-00661-y. J Biomed Sci. 2020. PMID: 32443983 Free PMC article. Review.
Cited by
-
Angiogenesis and Re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering.Front Bioeng Biotechnol. 2023 Feb 16;11:1103727. doi: 10.3389/fbioe.2023.1103727. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36873356 Free PMC article. Review.
-
Engineered Vasculature for Cancer Research and Regenerative Medicine.Micromachines (Basel). 2023 Apr 29;14(5):978. doi: 10.3390/mi14050978. Micromachines (Basel). 2023. PMID: 37241602 Free PMC article. Review.
-
Recent advances in extracellular matrix manipulation for kidney organoid research.Front Pharmacol. 2024 Nov 6;15:1472361. doi: 10.3389/fphar.2024.1472361. eCollection 2024. Front Pharmacol. 2024. PMID: 39568581 Free PMC article. Review.
-
Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions.Signal Transduct Target Ther. 2024 Jul 1;9(1):166. doi: 10.1038/s41392-024-01852-x. Signal Transduct Target Ther. 2024. PMID: 38945949 Free PMC article. Review.
-
Identification of the Factor That Leads Human Mesenchymal Stem Cell Lines into Decellularized Bone.Bioengineering (Basel). 2022 Sep 21;9(10):490. doi: 10.3390/bioengineering9100490. Bioengineering (Basel). 2022. PMID: 36290460 Free PMC article.
References
-
- Taguchi A., Kaku Y., Ohmori T., Sharmin S., Ogawa M., Sasaki H., Nishinakamura R., Cell Stem Cell 2014, 14, 53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources